Literature DB >> 10977781

Tubular osteopontin expression in human glomerulonephritis and renal vasculitis.

H Okada1, K Moriwaki, K Konishi, T Kobayashi, S Sugahara, H Nakamoto, T Saruta, H Suzuki.   

Abstract

Tubulointerstitial change is a common histopathologic feature of acute and chronic glomerular diseases and is more closely correlated than glomerular damage with renal function and subsequent outcome. Monocyte infiltration is presumed to be initiated by chemoattractants and has a pivotal role in tubulointerstitial changes. Osteopontin (OPN) is a candidate as such a chemoattractant and has been shown to recruit monocytes into the interstitium of animal models of renal diseases. In this study, we investigated OPN expression by immunostaining and its correlation with clinical and histopathologic parameters in patients with immunoglobulin A (IgA) nephropathy, diffuse proliferative lupus nephritis (DPLN), and myeloperoxidase-antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis (MMP). Twenty patients with IgA nephropathy, 12 patients with DPLN, and 14 patients with MMP were studied. OPN expression, which was constitutively observed on the apical membrane of distal tubules, was upregulated in the cytoplasm of proximal and distal tubular epithelium parallel to the degree of interstitial mononuclear cell infiltration in patients with IgA nephropathy, as well as those with DPLN. CD68(+) monocyte infiltration significantly correlated with the degree of OPN expression in the tubular epithelium. Conversely, there was no apparent induction of OPN in the proximal and distal tubular epithelium of patients with MMP despite remarkable monocyte infiltration. In conclusion, these data suggest that inducible expression of OPN in the tubular epithelium seems to be associated with interstitial monocyte infiltration and subsequent tubulointerstitial changes in some forms of human renal diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10977781     DOI: 10.1053/ajkd.2000.9790

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

1.  Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients.

Authors:  Marco Quaglia; Annalisa Chiocchetti; Tiziana Cena; Claudio Musetti; Sara Monti; Nausicaa Clemente; Umberto Dianzani; Corrado Magnani; Piero Stratta
Journal:  Clin Rheumatol       Date:  2014-05-13       Impact factor: 2.980

2.  Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine.

Authors:  Beom Jin Lim; Ji Hong Kim; Soon Won Hong; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

Review 3.  Biomarkers of acute kidney injury.

Authors:  Vishal S Vaidya; Michael A Ferguson; Joseph V Bonventre
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

4.  Effects of valproic acid and dexamethasone administration on early bio-markers and gene expression profile in acute kidney ischemia-reperfusion injury in the rat.

Authors:  Ryan W Speir; Jonathan D Stallings; Jared M Andrews; Mary S Gelnett; Timothy C Brand; Shashikumar K Salgar
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

5.  Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.

Authors:  Koji Kitagori; Hajime Yoshifuji; Takuma Oku; Chiyomi Sasaki; Hitomi Miyata; Keita P Mori; Toshiki Nakajima; Koichiro Ohmura; Daisuke Kawabata; Naoichiro Yukawa; Yoshitaka Imura; Kosaku Murakami; Ran Nakashima; Takashi Usui; Takao Fujii; Kaoru Sakai; Motoko Yanagita; Yoshitaka Hirayama; Tsuneyo Mimori
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

6.  Human apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunction.

Authors:  Makoto Asahina; Fumi Shimizu; Masayuki Ohta; Michiyasu Takeyama; Ryuichi Tozawa
Journal:  Exp Anim       Date:  2015-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.